DEFA14A: Others
Apr 25 14:44 ET
DEF 14A: Definitive information statements
Apr 25 14:44 ET
8-K: Current report
Apr 19 16:11 ET
Ligand Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 1 16:12 ET
Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27 07:25 ET
Ligand Pharmaceuticals | 8-K: Current report
Jan 8 00:00 ET
Ligand Pharmaceuticals | 8-K: Current report
Dec 1, 2023 08:25 ET
Ligand Pharmaceuticals | 8-K/A: Ligand Reports Third Quarter 2023 Financial Results
Nov 9, 2023 21:48 ET
Ligand Pharmaceuticals | 8-K: Ligand Reports Third Quarter 2023 Financial Results
Nov 8, 2023 16:08 ET
Ligand Pharmaceuticals | 8-K: Current report
Oct 18, 2023 09:03 ET
Ligand Pharmaceuticals | 8-K: Current report
Oct 17, 2023 19:24 ET
Ligand Pharmaceuticals | 8-K: Current report
Sep 27, 2023 08:38 ET
Ligand Pharmaceuticals | 8-K: Current report
Sep 18, 2023 17:26 ET
Ligand Pharmaceuticals | 8-K: Ligand Reports Second Quarter 2023 Financial Results
Aug 8, 2023 16:02 ET
Ligand Pharmaceuticals | 8-K: Current report
Jun 9, 2023 17:00 ET
Ligand Pharmaceuticals | 8-K: Ligand Reports First Quarter 2023 Financial Results
May 4, 2023 16:06 ET
Ligand Pharmaceuticals | DEFA14A: Others
Apr 20, 2023 16:07 ET
Ligand Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 20, 2023 16:05 ET
Ligand Pharmaceuticals | 8-K: Current report
Mar 13, 2023 08:02 ET
Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 22, 2023 16:05 ET
No Data
No Data